Benzinga Insights

Here’s How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years – Regeneron Pharmaceuticals (NASDAQ:REGN)

Regeneron Pharmaceuticals REGN has outperformed the market over the past 15 years by 10.66% on an annualized basis producing an average annual return of 22.46%. Currently, Regeneron Pharmaceuticals has a market capitalization of $64.44 billion. Buying $100 In REGN: If

Here’s How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years – Regeneron Pharmaceuticals (NASDAQ:REGN) Read More »

Comparing Amazon.com With Industry Competitors In Broadline Retail Industry – Amazon.com (NASDAQ:AMZN)

In today’s rapidly changing and highly competitive business world, it is imperative for investors and industry observers to carefully assess companies before making investment choices. In this article, we will undertake a comprehensive industry comparison, evaluating Amazon.com AMZN vis-à-vis its

Comparing Amazon.com With Industry Competitors In Broadline Retail Industry – Amazon.com (NASDAQ:AMZN) Read More »